Cas:130407-96-4 2-(3-Phenyl-1H-1,2,4-triazol-5-yl)benzonitrile manufacturer & supplier

Chemical Name:2-(3-Phenyl-1H-1,2,4-triazol-5-yl)benzonitrile

CAS.NO:130407-96-4

Synonyms:2-(3-Phenyl-1H-1,2,4-triazol-5-yl)benzonitrile

Molecular Formula:C₁₅H₁₀N₄

Molecular Weight:246.26700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:65.36000

Exact Mass:246.09100

LogP:3.01038

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(3-Phenyl-1H-1,2,4-triazol-5-yl)benzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(3-Phenyl-1H-1,2,4-triazol-5-yl)benzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(3-Phenyl-1H-1,2,4-triazol-5-yl)benzonitrile Use and application,2-(3-Phenyl-1H-1,2,4-triazol-5-yl)benzonitrile technical grade,usp/ep/jp grade.

Related News: Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact. 2-(3-Phenyl-1H-1,2,4-triazol-5-yl)benzonitrile manufacturer Speaking to Sky News, Raab said he could not confirm the ��precise number�� of those arriving into the UK on Sunday. 2-(3-Phenyl-1H-1,2,4-triazol-5-yl)benzonitrile supplier Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact. 2-(3-Phenyl-1H-1,2,4-triazol-5-yl)benzonitrile vendor Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated. 2-(3-Phenyl-1H-1,2,4-triazol-5-yl)benzonitrile factory Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.